(Q33957196)

English

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

scientific article published on September 1, 1975

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival (English)

1 reference

Europe PubMed Central

30 July 2017

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival (English)

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

author name string

B. G. Durie

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1182674

29 August 2022

S. E. Salmon

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1182674

29 August 2022

language of work or name

0 references

publication date

1 September 1975

1 reference

Europe PubMed Central

30 July 2017

full work available at URL

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%28197509%2936%3A3%3C842%3A%3AAID-CNCR2820360303%3E3.0.CO%3B2-U

Portable Document Format

online access status

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1182674

22 October 2023

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

1 reference

Europe PubMed Central

30 July 2017

36

1 reference

Europe PubMed Central

30 July 2017

842-854

1 reference

Europe PubMed Central

30 July 2017

3

1 reference

Europe PubMed Central

30 July 2017

Plasma cell myeloma. An interpretive review

2

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

The Treatment of Plasma Cell Myeloma

4

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

MYELOMA PROTEINS AND THE CLINICAL RESPONSE TO MELPHALAN THERAPY

5

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

Plasmacytic myeloma. A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients

7

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

Factors influencing the prognosis in myelomatosis

10

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

15

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

Quantitation of Total-Body Tumor Cells (MOPC 104E). I. Subcutaneous Tumor Model2

16

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

Cancer Research

17

29

2285

author name string

Goldin

publication date

1969

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

Prognosis of Myelomatosis on Treatment with Prednisone and Cytostatics

19

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

Urinary lysozyme, ribonuclease, and low-molecular-weight protein in renal disease.

20

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

Current studies in Hodgkin's disease: what laparotomy has wrought

21

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

Growth rates and responses to treatment in human myelomatosis

22

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

Prognostic factors in myelomatosis

24

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

Nonparametric Estimation from Incomplete Observations

25

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

The management of plasma cell neoplasms

29

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma.

30

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

"Solitary" myeloma of bone: a review of 12 cases

33

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

The formation of myeloma protein by a mouse plasma cell tumor

34

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

Interpretation of serum calcium in patients with abnormal serum proteins.

36

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

Urea, albumin, and response rates

37

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

The effect of Bence Jones protein on the in vitro function of rabbit renal cortex

38

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma

41

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

Cancer Research

43

29

2384

author name string

Schabel

publication date

1969

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

Thoughts on cancer chemotherapy and combination modality therapy (1974).

45

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

METABOLISM OF BENCE JONES PROTEINS.

46

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

Kinetics of tumor growth and regression in IgG multiple myeloma

47

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia

49

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

The role of the kidney in the catabolism of Bence Jones proteins and immunoglobulin fragments

50

1 reference

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

https://api.crossref.org/works/10.1002/1097-0142(197509)36:3%3C842::AID-CNCR2820360303%3E3.0.CO;2-U

22 October 2023

Identifiers

10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33957196&oldid=1995206189"